Compare COSM & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COSM | MLSS |
|---|---|---|
| Founded | 2009 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 20.8M |
| IPO Year | 2009 | 1996 |
| Metric | COSM | MLSS |
|---|---|---|
| Price | $0.38 | $0.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 663.1K | 146.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $54,426,402.00 | $8,629,928.00 |
| Revenue This Year | $20.69 | $8.95 |
| Revenue Next Year | $53.10 | $7.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.97 | N/A |
| 52 Week Low | $0.28 | $0.22 |
| 52 Week High | $1.32 | $1.11 |
| Indicator | COSM | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 39.49 | 49.96 |
| Support Level | $0.35 | $0.23 |
| Resistance Level | $0.50 | $0.31 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 27.07 | 55.50 |
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.